Sadagatullah, Abdul Nawfar
(2010)
The effect of monochromatic infrared energy therapy on diabetic feet with peripheral sensory
Neuropathy - a randomized controlled trial.
Infra red therapy.
Abstract
INTRODUCTION:
Peripheral diabetic neuropathy has been a burden to the health and economy with increasing number of the morbidity
and mortality following foot ulcer and amputation .
Being an irreversible disease, foot care and glycemic control is the mainstay of treatment. Various adjunct treatments
to improve neuropathy had been introduced to the market. Among them was Monochromatic Infrared Energy
Therapy (MIRE) which was claims to produce promising results. This study focused on the effect of MIRE on the
diabetic foot peripheral neuropathy. The main difference compared to other studies done before was the use of a
neurometer for neuropathy assessment which is more quantitative and sensitive .
OBJECTIVE:
To assess the effect of MIRE on diabetic feet associated with peripheral neuropathy
METHODOLOGY:
A randomized controlled single blinded study was conducted at Hospital Sains Malaysia from February to October
2008. A total of 30 lower limbs from 24 patients were enrolled into the study. The neuropathy was screened by
Michigan Neuropathy Scoring Investigation (MNSI) followed by the assessment of the Current Perception Threshold
using a neurometer at 2000Hz, 250Hz and 5Hz frequencies. The limbs were randomized to receive either daily
MIRE or placebo treatment for a total of 12 treatments. The foot was reassessed again with neurometer within a
week of completion of the treatment and at 6 weeks following treatment
RESULTS:
The data obtained was analyzed with non parametric test to compare between the pre-treatment and post treatment
groups. The inter relationship of each result between these 2 groups was confirmed by Chi-Square test. We found
that there was no significant difference (p>0.05) between the neuropathic foot of diabetic patient in both MIRE and
placebo groups .
CONCLUSION:
There was no improvement of neuropathy in the diabetic foot patient following MIRE treatment.
Actions (login required)
 |
View Item |
